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Cockayne syndrome (CS) is a rare autosomal recessive, multisystem disorder, belongs to the family of nucleotide excision repair diseases along with xeroderma 
pigmentosum. CS is caused by mutations in the gene CS Type A 
(CSA)/excision repair cross-complementing protein (ERCC) 
8 or CS Type B (CSB)/ERCC6 which provide instructions for 
repairing damaged DNA. Clinical features include failure to 
thrive, neurodevelopmental delay, cutaneous photosensitivity, 
pigmentary retinopathy, neurosensory hearing loss, dental caries, 
and cachectic dwarfism which are associated with the changes in the 
brain parenchyma [1-4]. The diagnosis is made by clinical features 
along with imaging features. CS includes a wide spectrum of 
clinical severity, which has been subdivided into four overlapping 
clinical subgroups of decreasing severity. Intracranial calcification 
and brain atrophy are seen in most of the individuals. Progression 
of syndrome leads to functional disability with multiple infections 
leads to death within in the 3rd decade of life [5,6]. Early diagnosis 
is very important for patient management and parental genetic 
counseling. We present a case of CS with its radiological profile 
which is helpful along with classical clinical profile to make the 
diagnosis of this rare syndrome [7-11].
CASE REPORT
A 7-year-old female presented with difficulty to stand from sitting 
position, difficulty in walking, photosensitive rash on face for 
7 months of age (which increases on exposure to sun), stunted 
growth, and not able to read and write.
Anthropometry measurements include: Weight - 10 kg 
(−6  SD), height - 88 cm (−5 SD), head circumference - 42 cm 
(−6 SD). On examination, she had short stature, microcephaly, 
mental retardation, triangular facies, facial rash (Fig. 1), 
low set ears, dental caries, mild hypotonia, and generalized 
proximal muscle weakness (Gower’s sign-positive). Ophthalmic 
examination showed photophobia and hereditary retinal 
degeneration with pallor of optic disc; no evidence of cataract or 
nystagmus; pupillary reactions were normal. Otorhinolaryngology 
examination was normal except for mild sensorineural hearing 
loss. Superficial and deep reflexes were reduced; cardiovascular, 
respiratory, and abdominal examination was within normal limits; 
routine blood biochemistry and serum creatine phosphokinase 
levels (248 U/L) were normal. Then, the patient was subjected 
to computed tomography (CT) followed by magnetic resonance 
imaging (MRI) brain study. CT brain showed bilateral putaminal 
calcification and few cortical calcifications (Fig. 2). The MRI of the 
brain, without a contrast study, showed generalized mild cerebral 
and cerebellar atrophies with widened sulci and an enlarged fourth 
ventricle, calcifications of the bilateral basal ganglia which are 
the classical features of CS (Figs. 3-5). MR spectroscopy showed 
normal NAA (N-acetylaspartate), choline, and creatinine peaks 
with decreased choline/creatine ratio and mildly increased lactate 
in some areas of white matter. The imaging features along with 
classical clinical features, we arrived the diagnosis of the CS. The 
parents of the patient have been explained the prognosis of the 
disorder and advised for the general care of patient according to 
the symptoms.
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DISCUSSION
The CS is an autosomal recessive, multisystem disorder with 
prevalence of 2 to 3 per million and male-to-female ratio of 3:1; 
classical clinical features include abnormal photosensitivity, 
retinitis pigmentosa, cachectic dwarfism, microcephaly, 
neurosensory deafness, and dental caries with progressive 
encephalopathy [1-4,12]. This syndrome often undetected in 
infancy, during which the growth and development are normal. 
The progressive degeneration is manifested by the 2nd or the 
3rd year of life. All classical features were noted in our patient 
except of proximal muscle weakness, which was also reported 
in literature with unknown etiology; it may be due to cerebellar 
involvement.
It encompasses a wide spectrum of clinical severity, which 
has been divided into four overlapping clinical subgroups of 
decreasing severity: Cerebro-oculo-facial-skeletal syndrome 
(COFS), CS II, CS I, and CS III. COFS is the most severe 
form, starting in utero or during the neonatal period with 
arthrogryposis, microphthalmia, and congenital cataracts and 
has a rapid fatal outcome. CS Type II begins and leads to 
death in infancy. CS Type I (the classic form) manifests during 
infancy, and death occurs in the 1st decades of life. CS Type III 
shows milder signs and follows a more protracted course into 
adulthood [5-8].
The basic pathology is deficient DNA repair mechanism due 
to mutation in gene CSA/ERCC8 and CSB/ERCC6 located on the 
chromosomes 5 and 10, respectively; mutations in these genes lead 
to a lack of recovery of RNA synthesis in cultured skin fibroblasts 
after ultraviolet irradiation, a key feature used as the major cellular 
Figure 3: T2WI axial images of MRI brain shows mild diffuse 
cerebral and cerebellar atrophy with prominence of ventricular 
system, white matter hyperintensities and hypointensity in bilateral 
lentiform nuclei (indicates calcification)
Figure 4: FLAIR axial images of MRI brain shows mild diffuse 
cerebral and cerebellar atrophy with prominence of ventricular 
system and diffuse white matter hyperintensities in periventricular 
and subcortical regions
Figure 2: Axial non contrast CT images of brain at the level of basal 
ganglia confirms calcifications in bilateral lentiform nuclei and few 
subcortical calcification in bilateral parietal lobes.
Figure 5: Axial T1WI brain MRI shows T1 hyperintensities in 
bilateral lentiform nuclei indicates calcification
Figure 1: Clinical photograph of 7 year old female shows, traingular 
face with rash, low set ears and dental caries
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diagnostic test for CS; this may well explain the cutaneous 
photosensitivity of patients with CS, but the pathophysiologic 
mechanisms behind the remaining clinical features are poorly 
understood. The neuropathologic changes include neuronal and 
myelin loss with deposits of calcium and iron in the vessels in 
the cerebellum, the basal ganglia, and the cerebrum [1,2]. The 
previously reported radiological findings of the CS include 
atrophy of the brain stem, cerebellum and the cerebrum, high 
signal intensity of the cerebral white matter on T2-weighted 
images and fluid-attenuated inversion recovery, calcifications 
of the dentate nucleus of the cerebellum, and the basal ganglia; 
subcortical calcification and calcified leptomeningeal vessels also 
described in literature [3]. Its diagnosis is based on the clinical 
diagnostic criteria, and it may be supported by the demonstration 
of the intracranial calcifications and MRI findings [5-10]. The 
calcification of the basal ganglia and the subcortical white 
matter may be detected on CT as early as 3 years of age [3]. 
MRI is a sensitive tool which can demonstrate the white matter 
hypomyelination [6].
The MRI in our patient showed diffuse white matter atrophy 
with demyelination (Figs. 3-5). Along with clinical and imaging 
features, diagnosis of CS was made, and parents were counseled 
regarding prognosis, natural course of disease, life expectancy, 
and 25% possibility of inheritance to offsprings; genetic analysis 
was not advised, because of classical radiological and clinical 
profile. From our observation, it was not possible to differentiate 
the CS from the other white matter diseases in the absence of 
the putaminal and few punctate subcortical calcifications. 
In the appropriate clinical settings, the MRI features such as 
hypomyelination, supratentorial white matter loss, cerebellar 
atrophy or hypoplasia, and bilateral basal ganglia calcifications 
are an important adjunct for supporting the diagnosis of the CS.
There is no definitive treatment available for CS and our 
patient was treated symptomatically; expected life expectancy 
may be up to the 3rd decade of life [5,12] which could not be 
prolonged by any type of treatment.
CONCLUSION
Hypomyelination, supratentorial white matter loss, cerebellar atrophy 
or hypoplasia, and bilateral basal ganglia calcifications are the most 
typical features in CS, which are often associated with the cortical 
calcifications in the early-onset types of the disease. These features 
can help in differentiating the CS from other leukodystrophies.
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